Bioventus Inc (BVS) Return on Assets ROA from the third quarter of 2026 to third quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Sep 26 2026 to Sep 27 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Bioventus Inc   (NASDAQ: BVS)


Bioventus Inc 's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Bioventus Inc 's ROA in the third quarter of 2026?
Bioventus Inc achieved a return on average assets (ROA) of 9.45 % in its third quarter of 2026, this is above BVS's average return on assets of -6.56%.
Bioventus Inc assets over the 12 months ending in its third quarter of 2026 are valued at $671 million

Despite the company's net income deteriorating, Bioventus Inc was able to improve its ROA compared to the second quarter of 2026.

However, within the Healthcare sector 101 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 26 2026 quarter, so far to 1171, from total ROA ranking in the second quarter of 2026 at 1621.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 26 2026)
III. Quarter		 (Jun 27 2026)
II. Quarter		 (Mar 28 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 27 2025)
III. Quarter
Y / Y Total Assets Change -2.97 % -4.73 % -4.49 % -5.23 % -8.18 %
Y / Y Net Income Change 49.45 % 290.48 % - - -
Net Income (TTM) in million 63 61 35 27 10
Return On Assets (TTM) 9.45 % 9.09 % 5.04 % 3.94 % 1.4 %
BVS's Total Ranking # 1171 # 1621 # 2026 # 2548 # 3054
Total Assets (TTM) in million 673 673 653 686 694
Seq. Total Assets Change 0.01 % 3.17 % -4.84 % -1.18 % -1.8 %
Seq. Net Income Change -83.46 % 817.51 % -77.21 % 332.3 % -56.79 %

BVS's 5 Years Annual ROA >> Back to BVS Management Effectiveness >> Compare BVS ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 31
Sector # 102
Overall # 635

Return On Assets Statistics
High Average Low
9.47 %
-6.56 %
-32.9 %
(Sep 26 2026)   (Jul 01 2023)





Financial Statements
Bioventus Inc 's Assets $ 673 million BVS's Balance sheet
Bioventus Inc 's Income $ 6 million Quarterly BVS's Income Statement
BVS's Income by Division See BVS's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change -5.23 % -9.42 % -41.15 % 12.19 % -
Total Assets in million 686 724 799 1,358 1,210
Y / Y Net Income Change - - - - -
Net Income in million 27 -44 -196 -213 10
Annual Return On Assets 3.98 % -6.06 % -24.49 % -15.72 % 0.79 %

BVS's 5 Years Annual ROA >> Back to BVS Management Effectiveness >> Compare BVS ROA to its Competitors



Comment on BVS's ROA in the fiscal year ending 2025
In the fiscal year 2025 ROA improved to 3.98 % compared to prior year, due to annual net income growth of % to $27.27 million, and due to decline of value in Bioventus Inc 's assets by -5.23 % to $685.85 million, compared to $685.85 a year before.


More Return On Assets Ratios
BVS's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
BVS's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for BVS's Competitors
Subscribers only: Roa for Bioventus Inc 's Suppliers
Subscribers only: Return On Assets for BVS's Customers

You may also want to know
BVS's Roi BVS's Inventory Turnover Ratio BVS's Growth Rates BVS's Dividend Comparisons
BVS's Profitability Ratios BVS's Asset Turnover Ratio BVS's Dividend Growth
BVS's Roe BVS's Valuation Ratios BVS's Financial Strength Ratios BVS's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 26 2026, within Healthcare Sector ROA
Caredx Inc   25.74 %
Medpace Holdings Inc   24.47 %
Acadia Pharmaceuticals Inc   21.60 %
Standard Biotools Inc   21.56 %
Eli Lilly And Company  21.24 %
Iradimed Corporation  20.89 %
Resmed Inc   18.67 %
Alector Inc   18.37 %
Corcept Therapeutics Inc  18.09 %
Chemed Corporation  17.73 %
Halozyme Therapeutics Inc   17.26 %
Pro dex Inc   16.75 %
Denali Therapeutics Inc   16.42 %
Krystal Biotech Inc   15.48 %
West Pharmaceutical Services Inc   15.47 %
Dexcom Inc   15.47 %
Intuitive Surgical Inc   14.71 %
Vertex Pharmaceuticals Inc  14.16 %
Neurocrine Biosciences Inc   13.69 %
Illumina Inc   13.43 %
Healthcare Services Group Inc   12.79 %
Kiniksa Pharmaceuticals International Plc  12.64 %
Tenet Healthcare Corp  12.39 %
Hca Healthcare Inc   11.73 %
Carlisle Companies Incorporated  11.72 %
Regeneron Pharmaceuticals Inc   11.50 %
Lantheus Holdings Inc   11.43 %
Msa Safety Inc  11.01 %
Encompass Health Corporation  10.99 %
Inspire Medical Systems inc   10.89 %

Date modified: 2026-11-03T16:39:58+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.